• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Edwards Lifesciences (NY: EW )

    70.88 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 196
    Open 70.88
    Bid (Size) 70.18 (1)
    Ask (Size) 71.24 (8)
    Prev. Close 70.88
    Today's Range 70.88 - 70.88
    52wk Range 58.93 - 95.73
    Shares Outstanding 602,400,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
    From Edwards Lifesciences Corporation
    Via Business Wire
    9 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga

    Performance

    YTD
    -6.21%
    -6.21%
    1 Month
    +13.64%
    +13.64%
    3 Month
    -18.57%
    -18.57%
    6 Month
    -17.72%
    -17.72%
    1 Year
    -6.77%
    -6.77%

    More News

    Read More
    Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
    Via Benzinga
    Top 3 Health Care Stocks That Are Set To Fly This Quarter
    Via Benzinga
    7 Leading MedTech Stocks for Next-Gen Health Solutions
    Via InvestorPlace
    How Is The Market Feeling About Edwards Lifesciences?
    Via Benzinga
    If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,200 Today
    Via Benzinga
    What 22 Analyst Ratings Have To Say About Edwards Lifesciences
    Via Benzinga
    Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow'
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Top 3 Health Care Stocks That May Explode In Q3
    Via Benzinga
    3 Healthcare Stocks to Buy at a 52-Week Low in July
    Via InvestorPlace
    Ford, Stellantis And Dell Are Among Top 12 Large Cap Losers Last Week (July 21-July 27): Are The Others In Your Portfolio?
    Via Benzinga
    Market Whales and Their Recent Bets on Edwards Lifesciences Options
    Via Benzinga
    These Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 Results
    Via Benzinga
    Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review
    Via Investor's Business Daily
    S&P 500, Nasdaq Settle Lower As Tech Stocks Continue To Falter: Greed Index In 'Fear' Zone
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Edwards Lifesciences Stock Tumbles, Highlights Slowdown In TAVR Business
    Via Benzinga
    Gold Down 2.5%; Northrop Grumman Posts Upbeat Earnings
    Via Benzinga
    Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
    Via Benzinga
    Stocks Bouncing Back After Data Hints At 'Soft Landing'
    Via Talk Markets
    Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
    Via Benzinga
    Topics Economy
    Exposures Economy
    This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
    Via Benzinga
    Ford Posts Downbeat Earnings, Joins MaxLinear, STMicroelectronics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
    Via Benzinga
    Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.